» Articles » PMID: 31206540

"I Take My Pills Every Day, but then It Goes Up, Goes Down. I Don't Know What's Going On": Perceptions of HIV Virological Failure in a Rural Context in Mozambique. A Qualitative Research Study

Overview
Journal PLoS One
Date 2019 Jun 18
PMID 31206540
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HIV prevalence in Mozambique is estimated to be 13.2%. Routine viral load for HIV monitoring was first implemented in the rural area of Tete in 2014. Programmatic data showed an unexpected high proportion of high viral load results, with up to 40% of patients having a viral load above 1000 copies/ml.

Objectives: This qualitative study aimed to explore perceptions about virological failure and viral load monitoring from the perspective of HIV positive patients on first-line antiretroviral therapy (ART) and health-care workers.

Methods: The study was conducted in seven rural communities in Changara-Marara district, Tete province, Mozambique. A total of 91 participants took part in in-depth interviews (IDIs) and focus group discussions (FGDs), including health-care workers (n = 18), patients on ART in individual care or Community Adherence Groups (CAGs) who experienced virological failure and virological re-suppression (n = 39) and CAG focal points (n = 34). Purposive sampling was used to select participants. Interviews and FGDs were conducted in Nhuengue and Portuguese. IDIs and FGDs were translated and transcribed before being coded and thematically analysed.

Results: Emergent themes showed that patients and health-care workers attributed great importance to viral load monitoring. A supressed viral load was viewed by participants as a predictor of good health and good adherence. However, some patients were confused and appeared distressed when confronted with virological failure. Viral load results were often little understood, especially when virological failure was detected despite good adherence. Inadequate explanations of causes of virological failure, delayed follow-up viral load results, repeated blood tests and lack of access to second-line ART resulted in reduced confidence in the effectiveness of ART, challenged the patient-provider relationship and disempowered patients and providers.

Conclusion: In this rural context undetectable viral load is recognized as a predictor of good health by people living with HIV and health-care workers. However, a lack of knowledge and health system barriers caused different responses in patients and health-care workers. Adapted counselling strategies, accelerated viral load follow-up and second-line ART initiation in patients with virological failure need to be prioritized.

Citing Articles

The potential promise and pitfalls of point-of-care viral load monitoring to expedite HIV treatment decision-making in rural Uganda: a qualitative study.

Rosen J, Ddaaki W, Nakyanjo N, Chang L, Vo A, Zhao T BMC Health Serv Res. 2024; 24(1):1265.

PMID: 39434090 PMC: 11494746. DOI: 10.1186/s12913-024-11747-w.


Validation of the HIV/AIDS-Targeted Quality of Life (HAT-QOL) for Evaluation of Health-related Quality of Life in People Living with HIV/AIDS in Brazil.

Valdelamar-Jimenez J, Narvaez Betancur M, Brites C, Lins-Kusterer L AIDS Behav. 2024; 28(12):4188-4198.

PMID: 39264484 DOI: 10.1007/s10461-024-04496-8.


Identifying longitudinal patterns of HIV treatment (dis)engagement and re-engagement from oral histories of virologically unsuppressed persons in Uganda: A thematic trajectory analysis.

Rosen J, Nakyanjo N, Ddaaki W, Zhao T, Vo A, Nakubulwa R Soc Sci Med. 2023; 339:116386.

PMID: 37984182 PMC: 10841599. DOI: 10.1016/j.socscimed.2023.116386.


Virological non-suppression among adult males attending HIV care services in the fishing communities in Bulisa district, Uganda.

Senteza I, Castelnuovo B, Mukunya D, Makumbi F PLoS One. 2023; 18(10):e0293057.

PMID: 37856568 PMC: 10586650. DOI: 10.1371/journal.pone.0293057.


Experiences and Perceptions on Community Client-Led ART Delivery (CCLADS) Model of Antiretroviral (ART) Delivery: Patients' and Providers' Perspectives in South Western Uganda.

Kasande M, Taremwa M, Tusimiirwe H, Lamulatu K, Amanyire M, Nakidde G HIV AIDS (Auckl). 2022; 14:539-551.

PMID: 36425751 PMC: 9680673. DOI: 10.2147/HIV.S387190.


References
1.
Kredo T, Ford N, Adeniyi F, Garner P . Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev. 2013; (6):CD009987. PMC: 10009870. DOI: 10.1002/14651858.CD009987.pub2. View

2.
Shubber Z, Mills E, Nachega J, Vreeman R, Freitas M, Bock P . Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Med. 2016; 13(11):e1002183. PMC: 5127502. DOI: 10.1371/journal.pmed.1002183. View

3.
Heestermans T, Browne J, Aitken S, Vervoort S, Klipstein-Grobusch K . Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: a systematic review. BMJ Glob Health. 2017; 1(4):e000125. PMC: 5321378. DOI: 10.1136/bmjgh-2016-000125. View

4.
Bemelmans M, Baert S, Negussie E, Bygrave H, Biot M, Jamet C . Sustaining the future of HIV counselling to reach 90-90-90: a regional country analysis. J Int AIDS Soc. 2016; 19(1):20751. PMC: 4870383. DOI: 10.7448/IAS.19.1.20751. View

5.
Decroo T, Telfer B, Biot M, Maikere J, Dezembro S, Cumba L . Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr. 2010; 56(2):e39-44. DOI: 10.1097/QAI.0b013e3182055138. View